Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, Sola Ortigosa J, Feito Rodriguez M, García-Doval I. Galván Casas C, et al. Among authors: figueras nart i. Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10. Br J Dermatol. 2020. PMID: 32348545 Free PMC article.
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria.
Curto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G, Cubiró X, Bonfill-Ortí M, Garcias-Ladaria J, Villar M, García-Navarro X, Bielsa-Marsol I, Vilavella M, Aparicio G, Baliu-Piqué C, Álvarez A, Lamas-Domenech N, Duran-Jordà X, Serra-Baldrich E, Giménez-Arnau A. Curto-Barredo L, et al. Among authors: figueras nart i. Br J Dermatol. 2018 Jul;179(1):210-212. doi: 10.1111/bjd.16379. Epub 2018 Apr 25. Br J Dermatol. 2018. PMID: 29368377 No abstract available.
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series.
Armario-Hita JC, Pereyra-Rodriguez J, Silvestre JF, Ruiz-Villaverde R, Valero A, Izu-Belloso R, Jáuregui-Presa I, Curto-Barredo L, Figueras-Nart I, Herranz-Pinto P, Herraez-Herrera L, Ortiz-de-Frutos FJ, Martinez-Pilar L, Sastre J, Serra-Baldrich E. Armario-Hita JC, et al. Among authors: figueras nart i. Br J Dermatol. 2019 Nov;181(5):1072-1074. doi: 10.1111/bjd.18041. Epub 2019 Jul 25. Br J Dermatol. 2019. PMID: 31021399 No abstract available.
Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
Carrascosa JM, Pastor-Nieto MA, Ruiz-González I, Silvestre JF, Borrego L, Gatica-Ortega ME, Giménez-Arnau AM; en representación del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC); Miembros del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC). Carrascosa JM, et al. Actas Dermosifiliogr (Engl Ed). 2020 Oct;111(8):650-654. doi: 10.1016/j.ad.2020.06.003. Epub 2020 Jul 2. Actas Dermosifiliogr (Engl Ed). 2020. PMID: 32622869 Free PMC article. English, Spanish.
Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
Exposito-Serrano V, Curto-Barredo L, Aguilera Peiro P, Gómez Armayones S, Serra-Baldrich E, Spertino J, Bonfill Ortí M, Figueras Nart I, Melé-Ninot G, Baliu-Piqué C, Sala Cunill A, Labrador-Horrillo M, Guilabert Vidal A, Fernández Chico N, Giménez-Arnau AM. Exposito-Serrano V, et al. Among authors: figueras nart i. Br J Dermatol. 2021 Jan;184(1):167-168. doi: 10.1111/bjd.19425. Epub 2020 Sep 2. Br J Dermatol. 2021. PMID: 32730636 No abstract available.
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
Pereyra-Rodríguez JJ, Herranz P, Ruiz-Villaverde R, Elosua-González M, Galán-Gutiérrez M, Figueras-Nart I, Miquel J, de la Cueva P, Serra-Baldrich E, Munera-Campos M, Melé-Ninot G, Expósito-Serrano V, Perez B, Serrano A, Ortiz de Frutos JF, Armario-Hita JC. Pereyra-Rodríguez JJ, et al. Among authors: figueras nart i. Clin Exp Dermatol. 2023 Aug 25;48(9):991-997. doi: 10.1093/ced/llad153. Clin Exp Dermatol. 2023. PMID: 37098171
Lichen sclerosus and its association with cancer: a retrospective cohort study.
Moreno-Vílchez C, Llobera-Ris C, Torrecilla-Vall-Llossera C, Notario J, Figueras-Nart I. Moreno-Vílchez C, et al. Among authors: figueras nart i. Int J Dermatol. 2023 Feb;62(2):e84-e85. doi: 10.1111/ijd.16218. Epub 2022 Apr 8. Int J Dermatol. 2023. PMID: 35394068 No abstract available.
Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis.
Melé-Ninot G, Curto-Barredo L, Bonfill-Ortí M, Expósito-Serrano V, Munera-Campos M, Figueras Nart I, Riquelme-Mc Loughlin C, Gómez-Armayones S, Spertino J, Serra-Baldrich E. Melé-Ninot G, et al. Among authors: figueras nart i. Australas J Dermatol. 2024 Mar;65(2):153-162. doi: 10.1111/ajd.14196. Epub 2023 Dec 6. Australas J Dermatol. 2024. PMID: 38058123
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?
Melé-Ninot G, Serra-Baldrich E, Spertino J, Guilarte M, Ribó González P, Lleonart-Bellfill R, Figueras-Nart I, Bonfill-Ortí M, Depreux N, Sala-Cunill A, Bielsa-Marsol I, Baliu-Piqué C, Sanmartín-Novell V, Garcia-Navarro X, Expósito-Serrano V, Garnica-Velandia D, Diaz-Sarrió MC, Gómez-Armayones S, Gich Saladich I, Giménez-Arnau A. Melé-Ninot G, et al. Among authors: figueras nart i. Eur J Dermatol. 2022 Sep 1;32(5):629-631. doi: 10.1684/ejd.2022.4334. Eur J Dermatol. 2022. PMID: 36468733 English.
32 results